About: John McMurray

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: John McMurray Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	researcher (en) 연구원 (ko) ricercatore (it) 研究者 (ja) araştırmacı (tr) wetenschapper (nl) дослідник (uk) эрдэмтэн (mn) वैज्ञानिक (hi) изилдөөчү (ky) 研究者 (zh) հետազոտող (hy)
rdfs:label	John McMurray (en) John McMurray (es) John McMurray (nl) John McMurray (sl) John McMurray (ast)
skos:prefLabel	John McMurray (en) John McMurray (es) John McMurray (nl) John McMurray (sl) John McMurray (ast)
name	John McMurray (en) John McMurray (es) John McMurray (nl) John McMurray (sl) John McMurray (ast)
Scopus author ID	wds:Q56633150-234FECBB-E221-499A-B0E0-8CF23A67C860
Scopus author ID	7202558724
given name	wds:Q56633150-560C24E5-08CC-414F-BF3B-7D643A62F0B8
given name	John
instance of	wds:Q56633150-6AAB4F91-475B-40B2-8A3A-C41F116004A9
instance of	Homo sapiens
award received	wds:Q56633150-48B29EDA-A4A0-44E5-A26D-C58F4C873872
award received	The Louis and Artur Lucian Award in Cardiovascular Diseases
ResearchGate profile ID	wds:Q56633150-BBE9F089-FD46-4EFA-AF77-F3791667D289
ResearchGate profile ID	John_Mcmurray2
Google Scholar author ID	wds:Q56633150-6279B962-B499-4F8C-88A2-66CC98C0FE2B
Google Scholar author ID	n0ZdRMoAAAAJ
Nationale Thesaurus voor Auteursnamen ID	wds:Q56633150-a0aeca82-f5be-488e-ae88-051aabd0dae7
occupation	wds:Q56633150-D41CA4B8-6551-4204-AF4C-C9E4299752C8
employer	wds:Q56633150-1627AFD0-89FD-4802-B504-6A3AAC2C6C8E wds:Q56633150-D725E375-2A27-460E-A064-519882122ECE
CONOR.SI ID	wds:Q56633150-F6C3A168-0C8D-4F70-8D16-B5E5BD6862A3
languages spoken, written or signed	wds:Q56633150-19D2B2FD-2A58-411E-8282-5203EA1A618A
sex or gender	wds:Q56633150-327576ca-4129-1dcf-0fcc-7f24425b27cf
VIAF ID	wds:Q56633150-D00D8481-422D-490B-95C4-0549C8145E68
FAST ID	wds:Q56633150-271958AE-727A-4B08-A889-7FE5F9F5D1F0
Library of Congress authority ID	wds:Q56633150-11A1D307-3B56-4CC2-9EE5-13C9DBED73F1
on focus list of Wikimedia project	wds:Q56633150-D35096D6-46FD-4A49-90E2-AE5105D2C0FA
family name	wds:Q56633150-EEA35169-7627-41F9-A8A7-E683615FE792
WorldCat Identities ID (superseded)	wds:Q56633150-5CD3CF58-275D-47D7-99D9-0A487555DC22
official website	wds:Q56633150-D2A85094-1494-4DC0-80A6-C4F4DE4D2DE6
Nationale Thesaurus voor Auteursnamen ID	http://data.bibliotheken.nl/id/thes/p189742127
VIAF ID	http://viaf.org/viaf/282651686
FAST ID	http://id.worldcat.org/fast/351099
Library of Congress authority ID	http://id.loc.gov/authorities/names/n95800028
Nationale Thesaurus voor Auteursnamen ID	189742127
occupation	researcher
employer	University of Southern Queensland University of Glasgow
CONOR.SI ID	144345955
languages spoken, written or signed	English
sex or gender	male
VIAF ID	282651686
FAST ID	351099
Library of Congress authority ID	n95800028
on focus list of Wikimedia project	WikiProject COVID-19
family name	McMurray
WorldCat Identities ID (superseded)	lccn-n95800028
official website	http://www.gla.ac.uk/researchinstitutes/icams/staff/johnmcmurray/
ORCID iD	wds:Q56633150-B901061C-F83F-4769-AAEF-E303263D0C69
ORCID iD	https://orcid.org/0000-0002-6317-3975
ORCID iD	0000-0002-6317-3975
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q56633150
is author of	Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study Sex differences in incidence, mortality, and survival in individuals with stroke in Scotland, 1986 to 2005. Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor Predictors of mortality and morbidity in patients with chronic heart failure Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Eplerenone in patients with systolic heart failure and mild symptoms Gender and survival: a population-based study of 201,114 men and women following a first acute myocardial infarction Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA). Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology Palliative care for heart failure Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology. Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland Impact of baseline physical activity and diet behavior on metabolic syndrome in a pharmaceutical trial: results from NAVIGATOR. A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics Angiotensin receptor blockers in heart failure Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial Influence of hospitalization for cardiovascular versus noncardiovascular reasons on subsequent mortality in patients with chronic heart failure across the spectrum of ejection fraction Anaemia is an independent predictor of mortality in patients with left ventricular systolic dysfunction following acute myocardial infarction☆ Influenza Vaccination in Patients With Chronic Heart Failure: The PARADIGM-HF Trial Developing therapies for heart failure with preserved ejection fraction: current state and future directions

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software